Bernard G. Francq, PhD in statistics, was a research associate at UCLouvain (Belgium) during the drafting of this manuscript and his collaboration in this research. His diverse career journey includes roles in non-clinical statistics in the pharma industry, biostatistical research in academia, and clinical trials at the University of Glasgow. Currently, he drives non-clinical statistical innovation at GSK. He is the principal author of the award-winning GSK Statistical Paper on tolerance intervals in bridging studies (Stat in Med, 2020) and has co-authored two of Wiley’s most downloaded papers (Stat in Med, 2019; Analytical Science Advances, 2022). His current research interests encompass design of experiments, (non)-linear mixed models, agreement studies, tolerance intervals, and (accelerated) stability analysis.
Bernard G. Francq, PhD in statistics, was a research associate at UCLouvain (Belgium) during the drafting of this manuscript and his collaboration in this research. His diverse career journey includes roles in non-clinical statistics in the pharma industry, biostatistical research in academia, and clinical trials at the University of Glasgow. Currently, he drives non-clinical statistical innovation at GSK. He is the principal author of the award-winning GSK Statistical Paper on tolerance intervals in bridging studies (Stat in Med, 2020) and has co-authored two of Wiley’s most downloaded papers (Stat in Med, 2019; Analytical Science Advances, 2022). His current research interests encompass design of experiments, (non)-linear mixed models, agreement studies, tolerance intervals, and (accelerated) stability analysis.